Pulse Biosciences Inc
Abrir
SetorSaúde
25.84 6.12
Visão Geral
Variação de preço das ações
24h
Mín
25.26
Máximo
26.07
Rendimento | -1.1M -19M |
|---|---|
Vendas | 137K 401K |
EPS | -0.241 |
Margem de lucro | -4,633.666 |
Funcionários | 116 |
EBITDA | -1.4M -19M |
Recomendações | Comprar |
|---|---|
Previsão para 12 meses | +27.21% upside |
Próximos Ganhos | 11 de ago. de 2026 |
|---|
Capitalização de Mercado | 179M 1.7B |
|---|---|
Abertura anterior | 19.72 |
Fecho anterior | 25.84 |
Sentimento de Notícias
By Acuity
34%
66%
94 / 342 Ranking em Healthcare
Pulse Biosciences Inc Gráfico
O desempenho passado não é um indicador confiável de resultados futuros.
Sobre Pulse Biosciences Inc
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
